Key Takeaway: Hims & Hers Health, Inc. has responded to a lawsuit filed by the FTC, claiming the lawsuit disregards evidence provided during a lengthy investigation. The company argues that the FTC's actions misinterpret telehealth laws and are aimed at generating negative publicity rather than protecting consumers. Hims & Hers asserts that the lawsuit is unfounded and misleading.
Market Sentiment Analysis
CONCERNS & RISKS
Lawsuit filed by the FTC against Hims & Hers.
Claims that the lawsuit ignores substantial evidence.
Accusations of misrepresentation of telehealth laws.
Concerns about the FTC's motives being more about headlines than consumer protection.
Full Press Release Details
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims. This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense. We are co
Frequently Asked Questions
What is the FTC lawsuit about?
The FTC lawsuit alleges violations related to telehealth practices by Hims & Hers.
How did Hims & Hers respond to the lawsuit?
Hims & Hers stated the lawsuit ignores substantial evidence and misrepresents the law.
What does Hims & Hers claim about the FTC's motives?
The company claims the FTC's actions are aimed at generating headlines rather than protecting consumers.
What evidence did Hims & Hers provide to the FTC?
Hims & Hers claims to have provided substantial evidence during the FTC's nearly three-year investigation.